Pharmacy

Drugmakers faced manufacturing dilemma during Hurricane Florence: 3 things to know

Many drug companies questioned whether they should shutter operations at their drug plants in the Carolinas and Virginia during Hurricane Florence, which would put the region's drug supply at risk, according to STAT. By Harrison Cook - 9/19/18
Drug prices soar after shortages, study finds

Amid a shortage, drug prices increase at roughly twice their usual rate, suggesting that pharma companies may be exploiting drug shortages to increase profits, according to a new study published in the Annals of Internal Medicine. By Alia Paavola - 9/18/18
Reputation save: Novartis links employee bonuses to ethical behavior

In an effort to save its reputation from the hit it took earlier this year, Swiss pharmaceutical giant Novartis revealed its employees will only get bonuses if they meet or exceed expectations for ethical behavior, according to Reuters. By Alia Paavola - 9/18/18

2nd toxin found in common heart drug, FDA warns

The FDA found a second toxin that may cause cancer in three lots of valsartan, a commonly prescribed drug to control blood pressure and prevent heart failure. By Alia Paavola - 9/17/18
How specialty pharmacy data can boost your drug's success

Data is valuable currency to your biopharmaceutical company. It can tell you how well your new specialty drug is working for patients—and point out ways to make it work even better. By Staff - 9/14/18
Bayer and Sanofi swap top executives: 5 things to know

Bayer AG and Sanofi, two drugmakers based in Europe, will swap top executives, according to Reuters. By Alia Paavola - 9/13/18
85% of Amazon Prime members would buy prescription drugs on the site, survey finds

Eighty-five percent of insured Amazon Prime members would be comfortable purchasing prescription drugs on the e-commerce giant's website, according to a Deutsche Bank study cited by CNBC. By Alia Paavola - 9/12/18

400% price hike for generic drug a 'moral requirement,' Missouri pharma CEO says

Nostrum Laboratories, a Missouri-based drugmaker, raised the price of a generic antibiotic 400 percent to more than $2,000 per bottle, and its CEO is defending the price hike, according to The Financial Times. By Alia Paavola - 9/11/18
Walgreens to buy pharmacy patient files from Fred's for $165M

Walgreens will purchase pharmacy patient prescription files and related inventory from 185 Fred's Pharmacy stores for $165 million, plus an amount equal to the value of related pharmacy inventory. By Alia Paavola - 9/10/18
Novartis to sell off part of generics business for $1B

Swiss pharma giant Novartis will sell part of its generic drug business, Sandoz, in a deal valued at $1 billion, reports the Wall Street Journal. By Alia Paavola - 9/7/18
Drugmakers raised the price of 60 drugs in August

Drugmakers increased the price of 60 products August — a sharp decline from July, which saw 110 price increases, according to a Wells Fargo drug-pricing report. By Alia Paavola - 9/7/18

7 things to know about insulin cost hikes

Despite public outrage over the high cost of insulin and drugmaker promises to halt price increases, they continued to climb from 2017 to 2018, according to a GoodRx analysis. By Alia Paavola - 9/6/18
Senate votes to ban pharmacy gag clauses: 5 things to know

In an effort to increase drug price transparency, the Senate passed a bill that would ban Medicare insurers from writing gag clauses into their contracts with pharmacists, according to The Washington Examiner. By Alia Paavola - 9/6/18
6 latest drug, medical device recalls

Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety. By Alia Paavola - 9/5/18
Bayer considers job cuts to shore up finances

To find financial wiggle room to compete with larger rivals, Bayer is considering job cuts and outsourcing, a person familiar with the discussion told Reuters. By Alia Paavola - 9/5/18
Hospitals mark up drugs by 479%: 6 report findings

On average, hospitals mark up prescription drugs by 479 percent, according to a new report from PhRMA, the drug industry's main lobbying group. By Alia Paavola - 9/5/18
Drug mix-up forces recall of asthma tablets

Camber Pharmaceuticals issued a voluntary recall of one lot of its Montelukast sodium tablets after the bottles were found to contain the wrong drug. By Alia Paavola - 9/4/18
FDA expands probe into common heart drugs linked to cancer: 5 things to know

The FDA is expanding its investigation into valsartan heart drugs, which are used to control blood pressure and prevent heart failure, after discovering an ingredient used in the products is a probable human carcinogen. By Alia Paavola - 8/31/18
Partners brings specialty pharmacy in-house, expects $23M in annual savings

In a move expected to save the health system $23 million annually, Boston-based Partners HealthCare has launched its own specialty pharmacy, according to The Boston Business Journal. By Alia Paavola - 8/31/18
Insys can't escape Aetna lawsuit alleging opioid fraud

Insys Therapeutics must face a lawsuit filed by Aetna that accuses the pharmaceutical company of defrauding the insurer into paying claims for the wrong type of opioid, a federal judge ruled Aug. 24, according to Reuters. By Morgan Haefner - 8/29/18

Page 1 of 50

«
Prev
1
2
3
4
5
6
7
8
9
10
Next
»

Top 40 Articles from the Past 6 Months